ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 939

$1.14M Total Retail Price of All Prescriptions

Rank: 29 out of 939

759 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 759 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

32% of this provider’s 759 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 16,191 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,146 556 S3 1 1
AMLODIPINE BESYLATE 936 697 2 6
FUROSEMIDE 848 577 3 7
SIMVASTATIN 806 648 4 2
POTASSIUM CHLORIDE 751 523 5 9
OMEPRAZOLE 574 436 6 5
LEVOTHYROXINE SODIUM 420 370 7 4
METOPROLOL TARTRATE 383 270 8 10
METFORMIN HCL 383 228 8 8
LISINOPRIL 370 265 10 3
HYDROCHLOROTHIAZIDE 335 233 11 12
TRAMADOL HCL 277 193 12 16
WARFARIN SODIUM 265 205 13 17
GABAPENTIN 253 156 14 11
CLONIDINE HCL 233 155 15 39
METOPROLOL SUCCINATE 228 159 16 21
CARVEDILOL 222 154 17 25
MELOXICAM 220 143 18 14
GLIMEPIRIDE 214 170 19 37
GLIPIZIDE ER 211 140 20 88
TRIAMTERENE-HCTZ 208 161 21 33
FAMOTIDINE 206 157 22 62
NEXIUM 201 141 23 18
DIOVAN 201 138 23 50
DONEPEZIL HCL 190 183 25 30
DIOVAN HCT 189 151 26 74
ATENOLOL 189 117 26 19
ALLOPURINOL 185 168 28 31
ATORVASTATIN CALCIUM 173 109 29 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 172 106 30 64
NIFEDIPINE ER 156 110 31 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 102 32 23
AMITRIPTYLINE HCL 150 67 R 33 38
ZOLPIDEM TARTRATE 144 74 34 20
CLOPIDOGREL 142 78 35 28
ALENDRONATE SODIUM 140 108 36 40
HYDRALAZINE HCL 140 96 36 130
CILOSTAZOL 137 116 38 219
TRIAMTERENE-HYDROCHLOROTHIAZID 136 91 39 115
NAPROXEN 135 71 40 72
PENTOXIFYLLINE 133 99 41 284
ISOSORBIDE MONONITRATE ER 132 109 42 53
ENALAPRIL MALEATE 131 86 43 65
IBANDRONATE SODIUM 128 104 44 312
PRAVASTATIN SODIUM 127 100 45 13
DIGOXIN 127 120 45 45
NABUMETONE 125 67 47 152
MEGESTROL ACETATE 122 118 R 48 136
ACTOS 121 98 49 141
NIASPAN 119 51 50 183
RANITIDINE HCL 117 60 51 35
INSULIN SYRINGE 114 66 52 97
NAMENDA 110 110 53 49
NOVOLOG 107 95 54 145
VENTOLIN HFA 107 51 54 80
ESCITALOPRAM OXALATE 106 80 56 61
ACARBOSE 105 64 57 321
RISPERIDONE 104 102 58 82
AMOX TR-POTASSIUM CLAVULANATE 104 55 58 144
AMLODIPINE BESYLATE-BENAZEPRIL 104 70 58 58
METHYLPREDNISOLONE 103 71 61 118
PROPYLTHIOURACIL 103 91 10 61 345
QUETIAPINE FUMARATE 102 89 63 69
SERTRALINE HCL 98 66 64 24
METOCLOPRAMIDE HCL 98 70 64 119
HALOPERIDOL 97 84 66 169
PLAVIX 95 62 67 48
ROPINIROLE HCL 95 66 67 78
PHENYTOIN SODIUM EXTENDED 95 46 67 99
RAMIPRIL 94 81 70 91
VERAPAMIL ER 94 51 70 85
ACETAMINOPHEN-CODEINE 93 39 S3 72 116
ADVAIR DISKUS 93 89 72 60
CRESTOR 93 20 72 34
AZITHROMYCIN 91 62 75 32
CIPROFLOXACIN HCL 91 66 75 54
AVODART 90 62 77 205
IBUPROFEN 90 46 77 112
INDAPAMIDE 89 62 79 173
LANSOPRAZOLE 85 77 80 177
LYRICA 84 42 81 63
LOSARTAN-HYDROCHLOROTHIAZIDE 84 68 81 55
PANTOPRAZOLE SODIUM 82 34 83 66
SPIRONOLACTONE 81 50 84 71
ZETIA 79 73 85 103
POLYETHYLENE GLYCOL 3350 79 41 85 57
PROMETHAZINE HCL 79 34 R 85 68
BUMETANIDE 78 72 88 124
CITALOPRAM HBR 77 63 89 15
SUCRALFATE 75 59 90 96
CYCLOBENZAPRINE HCL 73 20 R 91 36
BENAZEPRIL HCL 72 38 92 87
GEMFIBROZIL 70 31 93 100
TERBINAFINE HCL 68 51 94 367
JANUVIA 67 37 95 110
TEKTURNA 66 50 96 317
PROPRANOLOL HCL 64 49 97 117
LEVEMIR 64 51 97 168
KLOR-CON 8 64 41 97 250
TIZANIDINE HCL 63 22 100 81
LANTUS 62 27 101 59
BONIVA 60 43 102 380
MECLIZINE HCL 60 55 102 134
LOSARTAN POTASSIUM 60 34 102 29
LATANOPROST 60 44 102 233
FENTANYL 58 44 S2 106 104
GLYBURIDE-METFORMIN HCL 57 44 R 107 98
FLUCONAZOLE 56 29 108 140
CEPHALEXIN 55 40 109 77
CHLORZOXAZONE 54 21 R 110 249
NITROFURANTOIN MONO-MACRO 53 32 111 180
CELEBREX 53 45 111 106
GLYBURIDE 53 40 R 111 89
BENZTROPINE MESYLATE 52 43 R 114 175
DILTIAZEM 24HR CD 52 41 114 126
VYTORIN 51 50 116 216
MUPIROCIN 51 27 116 185
CYPROHEPTADINE HCL 50 26 R 118 318
SINGULAIR 50 32 118 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.